Latest Industry Insights

Variability in the quality of raw materials can not only impact production yields, but can also affect the quality, efficacy and safety of the final pharmaceutical product. In this interview, learn about how the capabilities of two handheld analyzers ensure reliable material identity verification.

We recently spoke with Thermo Fisher Scientific's Eric Grumbach, to learn more about the opening of the company's new Pharma and BioPharma Center, located in Shanghai, China. The center is set to support the rapid delivery of novel and high-quality therapeutics by providing expertise in critical analytical techniques and specialized workflows.

Technology Networks recently spoke with Johan van Hylckama Vlieg, Ph.D., Chief Scientific Officer at Kaleido Biosciences, to learn more about the development of Microbiome Metabolic Therapies (MMTs), and how Kaleido are advancing a pipeline of MMTs for a variety of disease indications.

With constant conversations examining the potential of CRISPR technology, it can be hard to focus on what has been achieved since 2012 and to look toward the future to determine what may be achievable both in the near – and longer – term.

Technology Networks recently spoke with Natalie Mount, CEO of Adaptate BioTherapeutics, to learn more about the company's aims and the challenges faced when developing immunotherapies and advancing them into clinical studies.

Recently, Thermo Fisher Scientific announced its membership of the Pistoia Alliance. At the Lab of the Future Congress 2019, we spoke with members of the Thermo Fisher team to learn more about the goals of joining the alliance, and what innovation means to Thermo Fisher.

As a stalwart in the biological and chemical analysis fields, JEOL celebrates its 70th anniversary this year. But that’s not all it is celebrating, with the appointment of 35-year veteran of JEOL USA, Bob Pohorenec as President of the company this year.

Trisha Rice, VP & GM Materials Science Business at Thermo Fisher Scientific, shares her experiences as a woman in science, and provides tips on how to be your most "authentic self" in the field.

In this week's instalment of "Technology Networks Explores the CRISPR Revolution", we're focusing on the technical elements of CRISPR technology. Helping us to answer key questions in this space is Dr Amy Butler, President of the Biosciences Division at Thermo Fisher Scientific.

To keep pace with progress in the biopharmaceutical industry, other technologies have also needed to advance. Mass spectrometry and liquid chromatography have similarly gained ground, innovating rapidly to meet the challenges and opportunities that this new type of therapeutic brings.